Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial
Lina Silva Salinas2021-07-29T22:37:53+02:00Honecker F, Harbeck N, Schnabel C, Wedding U, Waldenmaier D, Saupe S, Jäger E, Schmidt M, Kreienberg R, Müller L, Otremba B, Dorn J, Warm M Al-Batran SE, de Wit M; PELICAN investigators. J Geriatr Oncol. 2017 Oct 18. pii: S1879-4068(17)30195-9. doi: 10.1016/j.jgo.2017.09.009. [Epub ahead of print]